In ovarian cancer, BRCA1/2-mutated tumors with a higher level of neoantigens than those without alterations in HR genes and BRCA1/2 defects are associated with an increase of PD-L1 expression and T-cell infiltration (45, 46). Here, BRCA1 is linked to ovarian carcinoma.